SOBI:STO
Swedish Orphan Biovitrum AB (publ)
438,80 SEK
arrow_upward
+0,32%(+1,40) 1D
15 հոկ, 11:51:59 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
437,80 SEK
High
441,60 SEK
Low
436,20 SEK
Mkt. cap
156,93 մլրդ
Avg. vol.
255,84 հզր
Volume
39,44 հզր
P/E ratio
117,20
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 մլն
No. of employees
2 հզր
Open
437,80 SEK
High
441,60 SEK
Low
436,20 SEK
Mkt. cap
156,93 մլրդ
Avg. vol.
255,84 հզր
Volume
39,44 հզր
P/E ratio
117,20
52-wk high
487,00 SEK
52-wk low
293,60 SEK
EPS
3,74 SEK
Shares outstanding
357,64 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Simply Wall Street
·
12 րոպե առաջ
BioNTech (BNTX), What Is Behind The Latest Attention?
Stocktwits
·
54 րոպե առաջ
Why Are Nasdaq Futures Sinking Premarket? CRWV, MU, TSM, SKHY, IBRX, RKLB, TSLA Stocks In Focus
Yahoo Finance
·
29 րոպե առաջ
A Staggering 84% of S&P 500 Stocks Are Now in Correction Territory, and History Says This Foreshadows Disaster for Wall Street
Reuters
·
1 ժամ առաջ
Nasdaq futures dive 1% as AI rout deepens on debt concerns
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)